State Street: Thermo Fisher Scientific TMO Historial de posiciones en acciones
Comprado
Mantenidas
Vendido
| Trimestre | Valor de mercado | Estado | Acciones |
Cambio en la posición | Valor operado | Peso en el portafolio | Puesto en el portafolio | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q3 | USD 11.4 mil M | Compra |
16,892,592
+66,713
| +0.4% | +USD 39.6 M | 0.33% | 48 |
|
|
2026
Q2 | USD 8444 M | Compra |
16,825,879
+94,211
| +0.6% | +USD 45.2 M | 0.25% | 67 |
|
|
2026
Q1 | USD 8232 M | Compra |
16,731,668
+117,907
| +0.7% | +USD 64 M | 0.28% | 63 |
|
|
2025
Q4 | USD 9634 M | Compra |
16,613,761
+229,630
| +1% | +USD 130 M | 0.32% | 48 |
|
|
2025
Q3 | USD 7954 M | Venta |
16,384,131
-96,834
| -0.6% | -USD 45.1 M | 0.28% | 62 |
|
|
2025
Q2 | USD 6689 M | Venta |
16,480,965
-58,524
| -0.4% | -USD 24.5 M | 0.25% | 71 |
|
|
2025
Q1 | USD 8237 M | Compra |
16,539,489
+91,461
| +0.6% | +USD 49.5 M | 0.34% | 48 |
|
|
2024
Q4 | USD 8563 M | Compra |
16,448,028
+129,067
| +0.8% | +USD 71 M | 0.34% | 47 |
|
|
2024
Q3 | USD 10.1 mil M | Compra |
16,318,961
+124,996
| +0.8% | +USD 74 M | 0.41% | 39 |
|
|
2024
Q2 | USD 8962 M | Venta |
16,193,965
-389,979
| -2% | -USD 223 M | 0.39% | 42 |
|
|
2024
Q1 | USD 9645 M | Compra |
16,583,944
+107,060
| +0.6% | +USD 60.1 M | 0.43% | 38 |
|
|
2023
Q4 | USD 8751 M | Compra |
16,476,884
+835,295
| +5% | +USD 404 M | 0.43% | 40 |
|
|
2023
Q3 | USD 7923 M | Venta |
15,641,589
-475,367
| -3% | -USD 253 M | 0.44% | 37 |
|
|
2023
Q2 | USD 8415 M | Compra |
16,116,956
+55,458
| +0.3% | +USD 29.9 M | 0.44% | 36 |
|
|
2023
Q1 | USD 9263 M | Venta |
16,061,498
-223,763
| -1% | -USD 126 M | 0.52% | 32 |
|
|
2022
Q4 | USD 8973 M | Compra |
16,285,261
+126,385
| +0.8% | +USD 67 M | 0.53% | 31 |
|
|
2022
Q3 | USD 8200 M | Compra |
16,158,876
+135,437
| +0.8% | +USD 75.8 M | 0.52% | 31 |
|
|
2022
Q2 | USD 8710 M | Venta |
16,023,439
-194,196
| -1% | -USD 107 M | 0.52% | 31 |
|
|
2022
Q1 | USD 9584 M | Venta |
16,217,635
-5,538
| -0% | -USD 3.18 M | 0.47% | 33 |
|
|
2021
Q4 | USD 10.8 mil M | Compra |
16,223,173
+529,712
| +3% | +USD 331 M | 0.51% | 29 |
|
|
2021
Q3 | USD 8970 M | Compra |
15,693,461
+139,803
| +0.9% | +USD 76.7 M | 0.47% | 33 |
|
|
2021
Q2 | USD 7850 M | Compra |
15,553,658
+318,930
| +2% | +USD 150 M | 0.41% | 46 |
|
|
2021
Q1 | USD 6957 M | Venta |
15,234,728
-544,269
| -3% | -USD 260 M | 0.4% | 50 |
|
|
2020
Q4 | USD 7353 M | Venta |
15,778,997
-515,227
| -3% | -USD 242 M | 0.45% | 46 |
|
|
2020
Q3 | USD 7198 M | Venta |
16,294,224
-268,082
| -2% | -USD 111 M | 0.49% | 40 |
|
|
2020
Q2 | USD 6005 M | Compra |
16,562,306
+58,542
| +0.4% | +USD 19.6 M | 0.44% | 45 |
|
|
2020
Q1 | USD 4684 M | Compra |
16,503,764
+165,895
| +1% | +USD 52.3 M | 0.41% | 51 |
|
|
2019
Q4 | USD 5311 M | Compra |
16,337,869
+224,799
| +1% | +USD 68.2 M | 0.36% | 56 |
|
|
2019
Q3 | USD 4696 M | Venta |
16,113,070
-125,719
| -0.8% | -USD 36 M | 0.35% | 57 |
|
|
2019
Q2 | USD 4772 M | Venta |
16,238,789
-168,307
| -1% | -USD 46.4 M | 0.36% | 55 |
|
|
2019
Q1 | USD 4494 M | Compra |
16,407,096
+775,253
| +5% | +USD 193 M | 0.35% | 59 |
|
|
2018
Q4 | USD 3501 M | Compra |
15,631,843
+96,199
| +0.6% | +USD 22.6 M | 0.32% | 64 |
|
|
2018
Q3 | USD 3792 M | Compra |
15,535,644
+758,451
| +5% | +USD 174 M | 0.29% | 75 |
|
|
2018
Q2 | USD 3061 M | Venta |
14,777,193
-305,305
| -2% | -USD 64.8 M | 0.26% | 79 |
|
|
2018
Q1 | USD 3114 M | Venta |
15,082,498
-862,415
| -5% | -USD 181 M | 0.26% | 76 |
|
|
2017
Q4 | USD 3028 M | Compra |
15,944,913
+157,424
| +1% | +USD 30.2 M | 0.24% | 83 |
|
|
2017
Q3 | USD 2987 M | Venta |
15,787,489
-176,208
| -1% | -USD 31.9 M | 0.26% | 82 |
|
|
2017
Q2 | USD 2785 M | Venta |
15,963,697
-122,257
| -0.8% | -USD 20.5 M | 0.25% | 83 |
|
|
2017
Q1 | USD 2471 M | Compra |
16,085,954
+164,367
| +1% | +USD 25.1 M | 0.22% | 94 |
|
|
2016
Q4 | USD 2247 M | Compra |
15,921,587
+586,414
| +4% | +USD 86.5 M | 0.21% | 99 |
|
|
2016
Q3 | USD 2439 M | Compra |
15,335,173
+324,006
| +2% | +USD 49.9 M | 0.25% | 86 |
|
|
2016
Q2 | USD 2218 M | Venta |
15,011,167
-114,377
| -0.8% | -USD 16.9 M | 0.24% | 89 |
|
|
2016
Q1 | USD 2142 M | Venta |
15,125,544
-255,388
| -2% | -USD 34.2 M | 0.23% | 93 |
|
|
2015
Q4 | USD 2182 M | Compra |
15,380,932
+59,041
| +0.4% | +USD 7.87 M | 0.24% | 84 |
|
|
2015
Q3 | USD 1874 M | Venta |
15,321,891
-129,178
| -0.8% | -USD 16.8 M | 0.22% | 96 |
|
|
2015
Q2 | USD 2005 M | Venta |
15,451,069
-593,779
| -4% | -USD 77.4 M | 0.21% | 98 |
|
|
2015
Q1 | USD 2155 M | Venta |
16,044,848
-912,606
| -5% | -USD 118 M | 0.22% | 95 |
|
|
2014
Q4 | USD 2125 M | Compra |
16,957,454
+980,025
| +6% | +USD 119 M | 0.21% | 102 |
|
|
2014
Q3 | USD 1944 M | Compra |
15,977,429
+316,177
| +2% | +USD 38.4 M | 0.21% | 102 |
|
|
2014
Q2 | USD 1848 M | Compra |
15,661,252
+426,870
| +3% | +USD 50.2 M | 0.2% | 113 |
|
|
2014
Q1 | USD 1832 M | Compra |
15,234,382
+620,417
| +4% | +USD 73.8 M | 0.21% | 101 |
|
|
2013
Q4 | USD 1627 M | Compra |
14,613,965
+313,710
| +2% | +USD 31.2 M | 0.18% | 116 |
|
|
2013
Q3 | USD 1318 M | Venta |
14,300,255
-725
| -0% | -USD 65.6 k | 0.16% | 135 |
|
|
2013
Q2 | USD 1210 M | Compra |
+14,300,980
| Nuevas | +USD 1190 M | 0.16% | 134 |
|
Otros fondos que tienen TMO en su portafolio
Posición de State Street en TMO: resumen de T3 2026
State Street aumentó su participación en Thermo Fisher Scientific (TMO) en 0.4% durante T3 2026, al comprar aproximadamente USD 39.6 M y elevar la posición a 16,892,592 acciones con un valor de USD 11.4 mil M. La posición representa 0.33% del portafolio y ocupa el puesto #48.
State Street reportó por primera vez una posición en TMO en T2 2013 y desde entonces la ha mantenido en 54 trimestres. Al cierre de T3 2026, 2,797 fondos que sigue Wall St. Rank mantienen una posición en TMO.
- Al cierre de T3 2026, State Street tenía 16,892,592 acciones de Thermo Fisher Scientific con un valor de USD 11.4 mil M.
- State Street compró 66,713 acciones de Thermo Fisher Scientific en T3 2026, por un monto estimado de USD 39.6 M.
- Thermo Fisher Scientific representó el 0.33% del portafolio de State Street en T3 2026 y fue su posición número 48.
- State Street reportó por primera vez una posición en Thermo Fisher Scientific en T2 2013 y desde entonces la ha mantenido en 54 trimestres.
- Al cierre de T3 2026, 2,797 fondos que sigue Wall St. Rank tenían Thermo Fisher Scientific en su portafolio.
Según el informe 13F de State Street correspondiente a T3 2026, presentado el 12 nov 2026.